Thomas G. Wiggans - Dec 1, 2022 Form 4 Insider Report for PARDES BIOSCIENCES, INC. (PRDS)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Lacy, attorney-in-fact
Stock symbol
PRDS
Transactions as of
Dec 1, 2022
Transactions value $
$39,375
Form type
4
Date filed
12/5/2022, 03:21 PM
Previous filing
Oct 14, 2022
Next filing
Dec 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRDS Common Stock Purchase $26K +25K $1.04 25K Dec 1, 2022 Direct F1, F2
transaction PRDS Common Stock Purchase $13.4K +12.5K +50% $1.07 37.5K Dec 2, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $0.96025 to $1.05.
F2 The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
F3 The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $1.02 to $1.12.